Amantadine for chronic hepatitis C: a magic bullet or yet another dead duck?
- 1 October 2001
- journal article
- Published by Elsevier in Journal of Hepatology
- Vol. 35 (4), 527-530
- https://doi.org/10.1016/s0168-8278(01)00184-2
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Interferon plus amantadine versus interferon alone in the treatment of naı̈ve patients with chronic hepatitis C: a UK multicentre studyJournal of Hepatology, 2001
- Randomized, controlled trial with interferon-alpha (IFN-alpha) combined with ribavirin with and without amantadine sulfate in primary IFN-alpha nonresponsive patients with chronic hepatitis CJournal of Hepatology, 2001
- Interferon alpha2A induction therapy in combination with ribavirin and amantadine in naive patients with chronic HCV infectionJournal of Hepatology, 2001
- Pegylated (40 kda) interferon alfa-2A (PEGASYS®) in new combination therapies: a report of a randomized, multicenter efficacy and safety studyJournal of Hepatology, 2001
- Treatment of Chronic Hepatitis C with Amantadine Hydrochloride in Patients Who Had Not Responded to Previous Treatment with Interferon- and/or RibavirinClinical Infectious Diseases, 2001
- Pilot study of interferon-α high-dose induction therapy in combination with ribavirin plus amantadine for nonresponder patients with chronic hepatitis CZeitschrift für Gastroenterologie, 2001
- High daily dosing interferon-alpha in monotherapy, double and triple therapy of hepatitis C nonresponder patientsJournal of Hepatology, 2000
- Amantadine for chronic hepatitis CEuropean Journal of Gastroenterology & Hepatology, 2000
- Amantadine and Rimantadine Have No Direct Inhibitory Effects against Hepatitis C Viral Protease, Helicase, ATPase, Polymerase, and Internal Ribosomal Entry Site–Mediated TranslationThe Journal of Infectious Diseases, 2000
- Amantadine Monotherapy of Chronic Hepatitis C Patients Infected with Genotype 1bScandinavian Journal of Infectious Diseases, 2000